Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine
about
Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineA clinicopathological study of human yellow feverEvaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever VirusPersistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccineYellow Fever in Pará State, Amazon Region of Brazil, 1998-1999: Entomologic and Epidemiologic FindingsRecent Rapid Rise of a Permethrin Knock Down Resistance Allele in Aedes aegypti in MéxicoIdentification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues.Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced AntibodiesDetection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.Advances and controversies in yellow fever vaccinationQuestions regarding the safety and duration of immunity following live yellow fever vaccination.
P2860
Q26782367-67F8995F-0616-44EA-AE1B-1F2DE70B6A7FQ27469227-7C711AA7-349A-4DD6-AFB9-21CFAB37A93FQ27485366-0365AC5E-2D4F-4E85-AF72-E47173B681E3Q27486149-EA834574-F6A8-4D05-9285-693535C3A332Q27487826-3C4ADD30-754B-4E1A-AB93-82F7E9F5CB04Q27489888-F0ADB426-E261-41BB-AB0C-B4970E4FB19FQ33984371-AC34DA83-4CEC-4C9D-8AAA-0D7573CCA42BQ35210878-8B11E5AE-6192-41AE-9BDA-71D68AE16246Q35919750-03ED8110-5E39-4523-8C42-C8A9F6A6126BQ36450167-6FFF49D6-590A-4ABE-B1F0-C5F25B184D4BQ37166091-C40232E2-030D-4A00-8376-3EF7E1B5CF79Q37521917-2E143D6A-60D4-4A43-9E8F-148D832B8659Q37709619-0975FB0D-3C55-4C1E-91FA-C673B1014FB6Q39706701-3A79AE0A-A33A-4BB8-BCAB-11FBDCDCD856
P2860
Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine
description
1962 nî lūn-bûn
@nan
1962 թուականին հրատարակուած գիտական յօդուած
@hyw
1962 թվականին հրատարակված գիտական հոդված
@hy
1962年の論文
@ja
1962年学术文章
@wuu
1962年学术文章
@zh-cn
1962年学术文章
@zh-hans
1962年学术文章
@zh-my
1962年学术文章
@zh-sg
1962年學術文章
@yue
name
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@ast
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@en
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@nl
type
label
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@ast
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@en
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@nl
prefLabel
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@ast
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@en
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@nl
P2860
P1476
Neutralizing and haemagglutina ...... r vaccination with 17D vaccine
@en
P2093
P2860
P304
P407
P577
1962-01-01T00:00:00Z